VUFLOW

non-contact
real-time
vessel blood flow speeds

opportunity: 300M surgeries/year

$4M

50+
investors

REVENUE

expected
in 2022

WORLD CLASS

vision & robotics
engineering

IP

patents and
trade secrets

Featured in ...

Scinovia top emerging tech
Yahoo! Finance
Benzinga
crowdfunding on StartEngine
Inkwood interview

OVERVIEW

Future of assessing circulation in surgeries

VUFLOW is a unique non-contact, real-time system to help surgeons assess blood flow speeds (left image) in potentially hundreds of millions of major surgeries, where some form of revascularization may occur.

VUFLOW’s latest imaging head unit (right image) was tested with optional robotics upgrade (KUKA) that is targeted for availability in 2022.

point-n-image
to know-the-flow

VUFLOW imaging system is a mobile laboratory measurement instrument for fluid flow.

It operates 20 cm (8 inches) from the subject. And can measure speeds faster than 30 cm/s.

(current product shown)

VUFLOW R

Computer vision and robotics engineers and clinicians explore the latest medical robot arm and imaging head unit in a design facility.

VUFLOW R aims to provide surgeons with finger tip guidance that can record the path and automatically return to park or to the subject to save valuable time between measurements.

(optional robotics upgrade in 2022)

color speed map

speed graph

intuitive & informative

(left)
Easily visualize flow speeds as color map across an organ’s surface

(right)
Position the circle over an area of interest to image average flow speeds over time

growing market

Over 300M surgeries / year are performed.

The burgeoning blood flow measurement market has exceeded $500M / year.

Cutting and attaching blood vessels occurs in many types of  surgeries. Ending with good blood is key because it sustains organs and tissue with O2 and nutrients and removes CO2 and byproducts.

Scinovia is entering this growing market with VUFLOW, a non-contact, quantitative alternative for current users of contrast dye and ultrasound probes in over 500K cases / year.

THE PROBLEM

1) A key challenge surgeons face is knowing if a procedure has poor blood flow

20%

of bypass grafts were below 50% of targeted flow

14%

of breast reconstructions  have tissue death

2) Current methods (published in 1962) require contact, which have limitations

finger palpation

no speeds

contrast dye

no speeds
toxic

flow probe

vessel manipulation
limited placement

OUR SOLUTION

KNOW-THE-FLOW IN
REAL-TIME WITH VUFLOW

Probe and Dye tools can often predict cases that will end with poor flow or tissue death (necrosis).

Poor outcomes can result in longer recovery for people, costly complications, re-admissions, re-operations, or death.

We designed VUFLOW to be faster and easier to use than probes or dye because it is non-contact, non-contrast injection.

Simply point-n-image to visualize blood flow speeds.

PRODUCT COMPARISON


HYVE Laser angiographyLaser angiographyLaser ICG angiographyFlow probe

Flow probe for graft

Speeds in vessels--
Speeds in tissuepp-
non-device contact--
non-chemical-
non-ionizing--

capability: ✓  yes, p partial, –  no

HYVE created by Scinovia

BUSINESS MODEL

Pay-per-use convertible to a multi-year Software as a Service subscription agreement

Sell to current users of probes and dyes: Displace or complement existing modalities

SNAPSHOT

7 units

$4M and 7 years of R&D produced our technological advantage

REV target 2022

Partners in contract manufacturing and service support for US and Europe

world-class team

Led by top surgeon innovators and experts in compute vision software

IP

2 patents and 2 applications, plus trade secret algorithms

Updates

Inkwood interviews Scinovia on market entry
NC Biotech on Scinovia
WRAL TechWire on Scinovia
UNC's Lily Skip interviews founders
FDA Registered
Scinovia in Global Market Report

Contact

Name
This field is for validation purposes and should be left unchanged.